Cigna Investments Inc Repligen Corp Transaction History

Cigna Investments Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$161.19 - $257.96 $194,556 - $311,357	-1,207 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$247.59 - $304.47 $108,939 - $133,966	-440 Reduced 26.72%	1,207 $319,000
Q2 2021 Aug 10, 2021	SELL	$165.87 - $220.95 $32,012 - $42,643	-193 Reduced 10.49%	1,647 $329,000
Q1 2021 May 10, 2021	BUY	$180.37 - $226.26 $20,381 - $25,567	113 Added 6.54%	1,840 $358,000
Q4 2020 Feb 11, 2021	BUY	$148.08 - $206.57 $25,321 - $35,323	171 Added 10.99%	1,727 $331,000
Q3 2020 Nov 12, 2020	BUY	$122.51 - $158.27 $190,625 - $246,268	1,556 New	1,556 $230,000

487

54.4M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $6.92B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Cigna Investments Inc , based on Form 13F filings with the SEC.

Stay updated on Cigna Investments Inc with notifications on news.